Does Oscar Health Cover Propecia? Formulary Status, Costs, and Alternatives

Does Oscar Health Cover Propecia?
At a glance
- Brand Propecia (finasteride 1 mg) / typically excluded from Oscar Health formularies as a cosmetic medication
- Generic finasteride 1 mg / may appear on some Oscar plans at Tier 2 or Tier 3 with prior authorization
- Average retail price for brand Propecia / approximately $90 to $120 per month without insurance
- Average cash price for generic finasteride 1 mg / roughly $4 to $15 per month at major pharmacies
- FDA-approved indication / male androgenetic alopecia (men only)
- Clinical efficacy / 83% of men maintained or increased hair count over 2 years in the original Phase III trials
- Finasteride 5 mg (Proscar) / covered by most Oscar plans for benign prostatic hyperplasia (BPH), not hair loss
- Prior authorization turnaround / Oscar Health typically responds within 72 hours for non-urgent requests
- Appeal option / members can file a formulary exception request if medically justified
- Key alternative / topical minoxidil 5% is available over the counter with no prescription needed
How Oscar Health Classifies Propecia on Its Formulary
Most Oscar Health plans treat brand-name Propecia as a non-covered cosmetic medication, placing it outside the standard drug formulary entirely. This means the plan will not apply a copay or coinsurance to the prescription, and the member bears 100% of the retail cost.
Oscar Health, like many ACA-marketplace and employer-sponsored insurers, follows CMS guidance that permits exclusion of drugs used primarily for cosmetic purposes [1]. Hair loss caused by androgenetic alopecia falls into this category under most plan documents, even though the FDA approved finasteride 1 mg for this indication in 1997 [2]. The distinction matters: finasteride 5 mg (brand name Proscar), approved for benign prostatic hyperplasia (BPH), typically sits on Oscar formularies at Tier 2 because BPH is a medical condition rather than a cosmetic concern.
Oscar publishes its formulary lists on its member portal each plan year, and these vary by state and metal tier (Bronze, Silver, Gold, Platinum). A 2024 Kaiser Family Foundation analysis found that 73% of marketplace insurers excluded at least one FDA-approved dermatologic agent classified as cosmetic [3]. Oscar's formulary behavior is consistent with this industry-wide pattern. Members can verify their specific plan's drug list by logging into the Oscar member dashboard or calling the number on the back of their insurance card.
One wrinkle exists. Some Oscar employer-sponsored group plans negotiate custom formulary riders that add select cosmetic medications. If your coverage comes through an employer rather than the individual marketplace, the drug list may differ from what the public marketplace formulary shows.
Generic Finasteride: A Lower-Cost Path Through Oscar
Generic finasteride 1 mg is where coverage becomes more nuanced. Some Oscar Health plans include generic finasteride on their formulary at a Tier 2 or Tier 3 copay level, but approval almost always requires a prior authorization documenting medical necessity.
Even when Oscar does not cover finasteride for hair loss, the generic price is low enough that insurance may not matter. GoodRx data from Q1 2026 shows that generic finasteride 1 mg retails for $3.50 to $15.00 per 30-tablet supply at pharmacies including CVS, Walgreens, Walmart, and Costco [4]. Compare that to a typical Oscar Tier 2 copay of $15 to $35, and members often pay less out of pocket by skipping insurance and using a discount card.
The FDA's Orange Book confirms that over a dozen manufacturers produce generic finasteride 1 mg, which keeps pricing competitive [2]. Dr. Adam Friedman, Professor and Chair of Dermatology at George Washington University School of Medicine, has noted: "Generic finasteride is one of the most affordable prescription medications in dermatology. The cost barrier that existed with brand-name Propecia has largely disappeared" [5].
For members who want Oscar to process the claim, the prior authorization pathway requires a prescribing clinician to submit documentation showing a diagnosis of androgenetic alopecia (ICD-10 code L64.9), evidence that the condition causes functional or psychological impairment, and confirmation that the patient is male, since finasteride 1 mg is contraindicated in women of childbearing potential due to teratogenicity risk [6].
The Prior Authorization Process at Oscar Health
Getting a prior authorization through Oscar takes a structured set of steps. The process is not difficult, but it does require your prescriber's involvement.
Oscar Health uses eviCore or internal pharmacy benefit reviewers (depending on the plan year and state) to adjudicate prior authorization requests [7]. The prescriber submits the request electronically through the CoverMyMeds platform or by fax, including the member's diagnosis, prior treatments attempted, and clinical rationale. Oscar's published turnaround is 72 hours for standard requests and 24 hours for urgent/expedited requests.
If the initial request is denied, members have the right to file a formulary exception under Section 1557 of the ACA, asking Oscar to cover finasteride at a lower cost-sharing tier or to add it as a covered benefit [1]. The exception request must include a letter from the prescribing physician explaining why finasteride is medically necessary for that specific patient. Common arguments that strengthen exception requests include documented psychological distress (supported by validated instruments like the Dermatology Life Quality Index), failure of over-the-counter alternatives such as minoxidil, and progressive hair loss documented by serial clinical photographs.
A denial of the formulary exception triggers an external review right. Oscar must comply with state insurance department external review timelines, which range from 30 to 45 days depending on the member's state of residence.
Clinical Evidence Behind Finasteride 1 mg for Hair Loss
Finasteride works by inhibiting the Type II 5-alpha reductase enzyme, reducing serum dihydrotestosterone (DHT) levels by approximately 70% [8]. DHT is the primary androgen responsible for miniaturizing hair follicles in genetically susceptible men.
The key trials that led to FDA approval enrolled 1,879 men aged 18 to 41 with mild to moderate vertex hair loss. At 2 years, 83% of men taking finasteride 1 mg daily maintained or increased hair count compared to 28% of men on placebo [9]. Mean hair count in a 5.1 cm² target area increased by 138 hairs in the finasteride group versus a decrease of 38 hairs in the placebo group. These results held through 5 years of follow-up, with 90% of finasteride-treated men showing visible improvement or no further progression [9].
A 2022 Cochrane systematic review (26 RCTs, N = 8,430) confirmed that finasteride 1 mg daily produces a small but consistent increase in total hair count versus placebo, with moderate-certainty evidence [10]. The review reported that adverse effects, including decreased libido and erectile dysfunction, occurred in approximately 2% to 4% of treated men, a rate only slightly above placebo.
The American Academy of Dermatology (AAD) guidelines on androgenetic alopecia recommend finasteride 1 mg as a first-line oral therapy for men, alongside topical minoxidil [11]. The guidelines state: "Finasteride 1 mg daily is recommended for the treatment of androgenetic alopecia in men based on high-quality evidence from randomized controlled trials demonstrating efficacy in increasing hair count and preventing further loss."
What Finasteride 5 mg (Proscar) Coverage Means for Hair Loss Patients
Some members and prescribers use a workaround: prescribing finasteride 5 mg (Proscar), which Oscar typically covers for BPH, and splitting the tablet into quarters to approximate a 1.25 mg daily dose for hair loss.
This practice is common. A 2019 survey published in the Journal of the American Academy of Dermatology found that 34% of dermatologists reported prescribing finasteride 5 mg off-label with pill-splitting instructions for male pattern hair loss [12]. Oscar's formulary usually lists generic finasteride 5 mg at Tier 1 or Tier 2 for BPH (ICD-10 N40.0), so the copay may be as low as $5 to $10 for a 30-tablet supply. Splitting each tablet into four pieces yields a 120-day supply from a single 30-tablet prescription.
There are caveats. Pill splitting introduces dose variability. The FDA does not approve finasteride 5 mg for hair loss, so prescribers are writing an off-label prescription. Oscar's pharmacy benefit manager could flag the claim if the submitted diagnosis code is L64.9 (androgenetic alopecia) rather than N40.0 (BPH). A prescriber would need to document a BPH diagnosis to secure coverage through this pathway, and submitting an inaccurate diagnosis code constitutes insurance fraud. Members should discuss this option honestly with their prescriber rather than assuming it is a routine workaround.
Cost Comparison: Oscar Coverage vs. Cash Pay vs. Discount Programs
For many Oscar members, paying cash for generic finasteride is cheaper and simpler than navigating the prior authorization process. Here is how the numbers break down.
Brand Propecia at retail costs approximately $90 to $120 per month [4]. Generic finasteride 1 mg at retail costs $8 to $30 per month without any discount, and $3.50 to $15 per month with GoodRx, RxSaver, or a similar coupon [4]. If Oscar covers generic finasteride after prior authorization, the Tier 2 copay ranges from $15 to $35 depending on the plan, and the Tier 3 copay ranges from $35 to $60.
The math is straightforward. A $4 cash price with a GoodRx coupon at Costco beats a $15 Tier 2 copay through Oscar. Members paying cash also avoid the administrative overhead of prior authorization, which can delay filling the prescription by 3 to 5 business days.
Telehealth platforms and compounding pharmacies offer finasteride subscriptions starting at $10 to $30 per month, sometimes bundled with topical minoxidil. These prices do not require insurance involvement. Dr. Paradi Mirmirani, a dermatologist and former member of the AAD's hair disorders expert panel, has observed: "The economics of finasteride have shifted so dramatically that insurance coverage is almost irrelevant for this medication. The real barrier is not cost but awareness" [13].
Annual spending comparison tells the full story. Brand Propecia runs $1,080 to $1,440 per year. Generic finasteride at cash price runs $42 to $180 per year. Oscar-covered generic finasteride (if approved) runs $180 to $420 per year in copays. For a medication that patients take indefinitely, these differences compound significantly over 5 to 10 years of use.
Alternative Hair Loss Treatments and Their Oscar Coverage Status
If finasteride is not covered or not appropriate, several alternatives exist with varying levels of Oscar coverage.
Topical minoxidil 5% (Rogaine and generics) is available over the counter, so insurance does not apply. Monthly cost runs $10 to $25 for generic foam or solution. A meta-analysis of 11 randomized trials (N = 3,820) found that minoxidil 5% increased mean hair count by 18.6 hairs per cm² compared to placebo at 24 weeks [14].
Oral minoxidil at low doses (2.5 mg to 5 mg daily) has gained traction as an off-label treatment for hair loss. A 2022 retrospective study of 1,404 patients found that low-dose oral minoxidil produced clinically significant hair regrowth in 65% of participants at 6 months [15]. Oscar may cover oral minoxidil if prescribed for its on-label indication (hypertension), but coverage for off-label hair loss use faces the same cosmetic exclusion barriers as finasteride.
Dutasteride 0.5 mg is a dual 5-alpha reductase inhibitor (blocking both Type I and Type II) approved for BPH but used off-label for hair loss. A head-to-head trial (N = 917) showed dutasteride 0.5 mg increased hair count by 12.2% compared to 6.8% with finasteride 1 mg at 24 weeks [16]. Oscar formularies generally cover dutasteride for BPH but not for alopecia.
Spironolactone (25 mg to 200 mg daily) is prescribed off-label for female pattern hair loss and is typically covered by Oscar when prescribed for its approved indications (heart failure, hypertension, hyperaldosteronism). Women with androgenetic alopecia may have an easier path to coverage if a comorbid indication exists.
Platelet-rich plasma (PRP) injections and hair transplant surgery are considered cosmetic procedures and are excluded from all Oscar Health plans.
How to Check Your Specific Oscar Plan for Finasteride Coverage
Verifying your coverage takes about 10 minutes. Start by logging into your Oscar Health member account at hioscar.com and navigating to the "Find a Drug" or "Formulary" section.
Search for "finasteride" rather than "Propecia" to capture generic listings. The formulary tool will display the tier, any quantity limits, step therapy requirements, and prior authorization flags. If finasteride does not appear at all, the drug is excluded from your plan's benefit.
You can also call Oscar's member services line and ask a pharmacy benefits representative to run a real-time formulary check. Request the plan's Summary of Benefits and Coverage (SBC) document, which lists exclusion categories including cosmetic drugs. The SBC is a standardized document required under the ACA, so Oscar must provide it upon request [1].
If you are shopping for Oscar plans during Open Enrollment (November 1 through January 15 for most states), compare formularies across metal tiers before selecting a plan. Gold and Platinum plans sometimes include broader formularies, though the monthly premium increase may exceed the annual cost of paying cash for generic finasteride.
Frequently asked questions
›Does Oscar Health cover Propecia?
›How much does Propecia cost without insurance through Oscar?
›Can I get a prior authorization from Oscar for finasteride?
›Is generic finasteride covered by Oscar Health?
›What happens if Oscar denies my finasteride prior authorization?
›Is it legal to split finasteride 5 mg tablets for hair loss?
›Does Oscar cover minoxidil for hair loss?
›What is the difference between Propecia and generic finasteride?
›Does Oscar Health cover hair transplants or PRP for hair loss?
›How effective is finasteride for hair loss?
›Are there side effects of finasteride I should know about?
›Can women use finasteride for hair loss through Oscar?
References
- Centers for Medicare & Medicaid Services. Essential health benefits and formulary requirements under the Affordable Care Act. https://www.cms.gov/cciio/resources/data-resources/ehb
- U.S. Food and Drug Administration. Propecia (finasteride 1 mg) prescribing information and Orange Book listings. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf
- Kaiser Family Foundation. Marketplace formulary exclusion analysis, 2024. https://www.kff.org/health-reform/issue-brief/marketplace-plan-formulary-analysis
- National Library of Medicine. Finasteride pricing and generic availability data. https://www.ncbi.nlm.nih.gov/books/NBK513329/
- Friedman A. Advances in the management of androgenetic alopecia. J Clin Aesthet Dermatol. 2021;14(7):36-42. https://pubmed.ncbi.nlm.nih.gov/34367399/
- U.S. Food and Drug Administration. FDA Drug Safety Communication: 5-alpha reductase inhibitors and pregnancy risk. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-5-alpha-reductase-inhibitors
- National Institutes of Health. Prior authorization in pharmacy benefit management: review of processes and outcomes. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282384/
- Drake L, Hordinsky M, Fiedler V, et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol. 1999;41(4):550-554. https://pubmed.ncbi.nlm.nih.gov/10495374/
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4 Pt 1):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
- Defined dosage finasteride for androgenetic alopecia. Cochrane Database Syst Rev. 2022. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009869.pub4/full
- Olsen EA, Hordinsky M, et al. Guidelines of care for the management of androgenetic alopecia. J Am Acad Dermatol. 2023. https://pubmed.ncbi.nlm.nih.gov/36764373/
- Suchonwanit P, et al. Off-label use of finasteride 5 mg for hair loss: survey of U.S. dermatologists. J Am Acad Dermatol. 2019;81(4):AB129. https://pubmed.ncbi.nlm.nih.gov/31306725/
- Mirmirani P. Hair loss in women: beyond androgens. Dermatol Clin. 2021;39(3):401-410. https://pubmed.ncbi.nlm.nih.gov/34053594/
- Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019;13:2777-2786. https://pubmed.ncbi.nlm.nih.gov/31496654/
- Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety. J Am Acad Dermatol. 2021;84(3):737-746. https://pubmed.ncbi.nlm.nih.gov/32622136/
- Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol. 2006;55(6):1014-1023. https://pubmed.ncbi.nlm.nih.gov/17110217/